Both the Y3.3UVRc34 mouse and anti-PD1 responding human tumors showed infiltration with tumor-specific CD8 T cells exhibiting high expression of the PD1 inhibitory checkpoint, while its ligand PD-L1 was highly expressed on both tumor cells and TME. The gene discussed is CD8A; the disease is neoplasm.